Richard Daniell, EVP, Europe Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 17,295 shares at $31.67 ($548K) on 2026-03-05, disclosed to the SEC on 2026-03-09.
Scheduled sale ($548k) by EVP, Europe Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |
| TEVA | SELL | 2025-03-07 | $2.3M | — | Filing → |